| |
| |
|
| Insider
Information: |
Alphabet Inc. |
| Relationship: |
10% Owner |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
31,942,641 |
|
|
Indirect Shares
|
73,738,852 |
|
|
| Direct
Value |
$60,691,018 |
|
|
|
Indirect Value
|
$278,911,470 |
|
|
| Total
Shares |
105,681,493 |
|
|
| Total
Value |
$339,602,488 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
12
|
23
|
|
Stock
price went up :
|
11
|
17
|
| Stock
price went down : |
1
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
11.0
|
2.8
|
| Percentage
Gain/Loss : |
 65.7%
|
1,898.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcus Biosciences Inc |
RCUS |
10% Owner |
2018-03-19 |
0 |
2018-03-19 |
1,924,474 |
Premium* |
|
|
X4 Pharmaceuticals Inc |
XFOR |
10% Owner |
2017-11-20 |
0 |
2017-11-20 |
451,362 |
Premium* |
|
|
Armo Biosciences Inc |
ARMO |
10% Owner |
2018-01-30 |
0 |
2018-01-30 |
607,350 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
10% Owner |
2018-06-25 |
0 |
2018-06-25 |
3,339,137 |
Premium* |
|
|
Crowdstrike Holdings, Inc. |
CRWD |
10% Owner |
2019-06-14 |
0 |
2020-02-20 |
140,000 |
Premium* |
|
|
Duolingo, Inc. |
DUOL |
10% Owner |
2021-07-30 |
0 |
2021-07-30 |
0 |
Premium* |
|
|
Freshworks Inc. |
FRSH |
10% Owner |
2021-11-16 |
0 |
2021-11-22 |
2,094,204 |
Premium* |
|
|
Planet Labs PBC |
PL |
10% Owner |
2021-12-07 |
31,942,641 |
|
0 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
|
0 |
2022-04-11 |
0 |
Premium* |
|
|
Gitlab Inc. |
GTLB |
Member of 10% Group |
2022-05-10 |
0 |
2023-05-05 |
2,647,312 |
Premium* |
|
|
Prime Medicine, Inc. |
PRME |
10% Owner |
2022-10-24 |
0 |
2024-02-20 |
3,200,000 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
|
2022-10-31 |
0 |
2023-12-01 |
1,800,000 |
Premium* |
|
|
Insynergy Products, Inc |
ISYG |
10% Owner |
|
0 |
2023-02-15 |
57,535,013 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
142 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRME |
Prime Medicine, Inc. |
Member of a 10% Group |
– – – |
2022-10-24 |
4 |
B |
$17.00 |
$13,600,000 |
I/I |
800,000 |
11,522,248 |
0.01 |
% |
|
| PRME |
Prime Medicine, Inc. |
Member of a 10% Group |
– – – |
2022-10-24 |
4 |
A |
$0.00 |
$0 |
I/I |
12,484,688 |
1,762,440 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-10-31 |
4 |
AS |
$37.91 |
$4,149,325 |
I/I |
(107,393) |
4,418,813 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-10-31 |
4 |
AS |
$0.00 |
$0 |
I/I |
(53,697) |
6,267,208 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-01 |
4 |
AS |
$0.00 |
$0 |
I/I |
(31,963) |
6,235,245 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-01 |
4 |
AS |
$36.69 |
$2,351,706 |
I/I |
(63,926) |
4,386,850 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-02 |
4 |
AS |
$0.00 |
$0 |
I/I |
(28,651) |
6,206,594 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-02 |
4 |
AS |
$34.78 |
$2,059,630 |
I/I |
(57,303) |
4,358,198 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-03 |
4 |
AS |
$0.00 |
$0 |
I/I |
(49,569) |
6,157,025 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-03 |
4 |
AS |
$32.32 |
$3,251,028 |
I/I |
(99,137) |
4,308,630 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-04 |
4 |
AS |
$0.00 |
$0 |
I/I |
(48,583) |
6,108,442 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-04 |
4 |
AS |
$31.12 |
$3,025,611 |
I/I |
(97,166) |
4,260,047 |
0 |
- |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2022-11-04 |
4 |
B |
$35.53 |
$9,991,257 |
I/I |
277,493 |
870,895 |
0.01 |
% |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2022-11-07 |
4 |
B |
$34.91 |
$7,098,803 |
I/I |
201,897 |
1,072,792 |
0.01 |
% |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2022-11-08 |
4 |
B |
$35.97 |
$1,428,187 |
I/I |
39,423 |
1,112,215 |
0.01 |
% |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2022-11-09 |
4 |
B |
$34.29 |
$6,307,812 |
I/I |
182,312 |
1,294,527 |
0.01 |
% |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2023-05-03 |
4 |
B |
$28.30 |
$8,784,328 |
I/I |
309,931 |
2,243,665 |
0.01 |
% |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2023-05-04 |
4 |
B |
$26.75 |
$10,689,665 |
I/I |
396,361 |
2,640,026 |
0.01 |
% |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2023-05-05 |
4 |
B |
$26.98 |
$196,584 |
I/I |
7,286 |
2,647,312 |
0.01 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-08 |
4 |
AS |
$14.13 |
$1,423,727 |
I/I |
(100,772) |
11,421,476 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-09 |
4 |
AS |
$14.08 |
$4,522,613 |
I/I |
(321,238) |
11,100,238 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-10 |
4 |
AS |
$14.03 |
$1,225,804 |
I/I |
(87,397) |
11,012,841 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-11 |
4 |
AS |
$12.98 |
$349,533 |
I/I |
(26,626) |
10,986,215 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-12 |
4 |
AS |
$12.72 |
$347,222 |
I/I |
(27,290) |
10,958,925 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-15 |
4 |
AS |
$12.74 |
$2,012,087 |
I/I |
(157,952) |
10,800,973 |
0 |
% |
|
142 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
